Don Munoz

Don Munoz currently serves as Chief Financial Officer of NuCana plc, a Nasdaq-listed biotechnology company focused on significantly improving treatment outcomes for patients with cancer. Prior to joining NuCana in 2015, Don served as Group Chief Financial Officer of NOXXON Pharma. He has an extensive financial background with approximately 20 years as a healthcare investment banker at Alex. Brown & Sons, Deutsche Bank, Leerink Partners and Cowen. Don has completed over 100 financing and merger and acquisition transactions with an aggregate value of more than $30 billion. He received an MBA in Finance and Accounting from Columbia Business School and an AB in Psychology from Dartmouth College.